Tag: Pharmaceutical industry
Incentives for pharmaceutical companies: Lauterbach wants to take action against resistant bacteria
Incentives for pharmaceutical companies Lauterbach wants to take action against resistant bacteria 02/09/2023, 08:15 am Every year more than 35,000 people in the European Economic Area die from antibiotic resistance.…
Ongoing criticism: Bayer boss Baumann resigns prematurely
persistent criticism Bayer boss Baumann resigns prematurely 2/8/2023 5:31 p.m Bayer boss Baumann has been under pressure for months. The reason for this is the ongoing problems caused by the…
During the visit of the Federal Chancellor: Biontech announces its own plasmid production
During the visit of the Federal Chancellor Biontech announces its own plasmid production 2/2/2023 6:23 p.m While the Chancellor is visiting the Marburg plant, Biontech boss Sahin announces an expansion…
Criticism of pricing policy in Europe: meager income cloud Novartis’ shareholder wellness
Criticism of pricing policy in Europe Meager revenues cloud Novartis’ shareholder wellness 2/1/2023, 6:17 p.m Novartis flatters its shareholders with a higher dividend and additional billions for a possible share…
Billions in revenue expected: Bayer heralds the era of the next pharmaceutical blockbuster
Expected billions in revenue Bayer ushers in the era of the next pharmaceutical blockbuster 01/10/2023 4:52 p.m Bayer’s pharmaceutical revenues are bubbling up for a long time thanks to the…
InstaDeep is the largest acquisition: Biontech buys British AI startup
InstaDeep is the largest acquisition Biontech buys British AI startup 01/10/2023, 4:55 p.m Biontech wants to expand its capacities in the field of immunotherapies. To do this, the Mainz-based company…
Positive study data: ray of hope for Curevac – share price picks up again
Positive study data Ray of hope for Curevac – share price picks up again 1/9/2023 4:43 p.m Curevac is repositioning itself at the top. The new combined vaccination against influenza…
Exploding costs, prices down: fever juice is simply too expensive for manufacturers
Rapidly increasing costs for active ingredients and production make the manufacture of medicines such as fever syrups a loss-making business. With dramatic consequences – not only for domestic companies. While…
“The situation is bad”: pharmacies criticize supply bottlenecks for medicines
“The situation is bad” Pharmacies criticize delivery bottlenecks for medicines 11/19/2022 11:04 am Although there has not yet been a shortage of medicines for patients in Germany, pharmacists are sounding…
Legal disputes are getting cheaper: Bayer full of confidence after a strong summer
Litigation becomes cheaper Bayer full of confidence after a strong summer 11/08/2022 3:49 p.m The DAX group Bayer sees itself on course to achieve the recently raised annual targets. The…
Energy crisis and collective bargaining: The chemical and pharmaceutical industries see themselves in acute danger
Energy crisis and tariff talks The chemical and pharmaceutical industries see themselves in acute danger 09/28/2022, 8:40 p.m Collective bargaining will continue in the chemical and pharmaceutical industries in mid-October.…
Steel, chemicals and car manufacturers: this is how large companies want to save energy
Steel, chemicals and car manufacturers This is how large companies want to save energy 8/3/2022, 4:44 p.m A gas crisis threatens in winter, and there are also risks with electricity.…